r e s o u r c e Mast cells are evolutionarily ancient sentinel cells. Like basophils, mast cells express the high-affinity receptor for immunoglobulin E (IgE) and have been linked to host defense and diverse immune-system-mediated diseases. To better characterize the function of these cells, we assessed the transcriptional profiles of mast cells isolated from peripheral connective tissues and basophils isolated from spleen and blood. We found that mast cells were transcriptionally distinct, clustering independently from all other profiled cells, and that mast cells demonstrated considerably greater heterogeneity across tissues than previously appreciated. We observed minimal homology between mast cells and basophils, which shared more overlap with other circulating granulocytes than with mast cells. The derivation of mast-cell and basophil transcriptional signatures underscores their differential capacities to detect environmental signals and influence the inflammatory milieu.
The Immunologic Genome (ImmGen) Project is a consortium of immunologists and computational biologists who seek to determine the gene-expression patterns that characterize the mouse immune system through rigorously standardized cell-isolation protocols and data-analysis pipelines 1 . Tissue-resident mast cells and circulating basophils are granulocytes traditionally associated with type 2 inflammation and host defense against helminthic infection 2 . Here we assessed the gene-expression profiles associated with these populations and placed them within the broader context of the immune system using the power of the ImmGen compendium.
Mast cells are evolutionarily ancient cells that date back at least as far as urochordates 3, 4 , which predates the emergence of adaptive immunity. Mast cells are morphologically distinct tissue-resident sentinel cells densely packed with secretory granules containing preformed mediators, including histamine, TNF, serotonin and a broad range of mast-cell-specific serine proteases bound to a proteoglycan core with heparin glycosaminoglycans 5 . Granule release following mast-cell activation is accompanied by the generation of pro-inflammatory leukotrienes, prostaglandins, chemokines and cytokines 5, 6 . This array of mediators is central to the mast cell's sentinel function in mediating host resistance to bacteria, multicellular parasites and xenobiotic venoms [7] [8] [9] . Mast cells can be activated through patternrecognition receptors 9 or tissue damage 10, 11 and express FcεR1 and Fcγ receptors, which allows them to respond to targets of the adaptive immune system 2 .
Mast cells are found in two main peripheral tissue compartments. Mucosal mast cells, absent in T cell-deficient humans and mice 12 , arise from bone marrow (BM)-derived agranular mast-cell progenitors. These progenitors constitutively home to the intestinal mucosa 13 and are further recruited to the intestine 14 and lung 15 during T cell-mediated inflammation, which directs their maturation into 1 Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, Massachusetts, USA. 2 Harvard Medical School, Boston, Massachusetts, USA. 3 Full list of members and affiliations appears at the end of the paper. 4 Expression profiling of constitutive mast cells reveals a unique identity within the immune system Daniel F Dwyer 1,2 , Nora A Barrett 1,2,4 , K Frank Austen 1,2,4 & The Immunological Genome Project Consortium 3 granulated mucosal mast cells 16 . In contrast to mucosal mast cells, connective-tissue mast cells are constitutively present in most connective tissues 17 and are seeded during embryogenesis by circulating progenitors derived from the fetal liver 18 . BM-transfer experiments in adult mice have shown poor engraftment of donor-derived mast cells in connective tissues relative to their recruitment to mucosal sites 19 , which suggests that the connective-tissue mast-cell compartment is maintained through longevity or self-renewal rather than replacement by BM-derived precursor cells. While studies have indicated that mast-cell expression of proteases 16, 20 and receptors 21 is heterogeneous and is regulated by the tissue microenvironment, the full degree of mast-cell heterogeneity across different tissues is unknown.
Compared with mast cells, basophils are smaller circulating cells with multi-lobular nuclei and fewer, smaller cytoplasmic granules containing histamine and a restricted protease profile 22, 23 . Basophils infiltrate peripheral tissue during allergic inflammation 24 and, like mast cells, express FcεR1. Signaling through FcεR1 induces basophil degranulation, accompanied by the rapid generation of leukotrienes and cytokines, including interleukin 4 (IL-4) and 26) . Unlike connective-tissue mast cells, circulating basophils are shortlived, with a half-life of several days in the periphery 27 , and are actively replenished from a progenitor cell 28 . Due to their FcεR1 expression and mediators produced, mast cells and basophils have been believed to be closely related.
The contribution of mast cells to inflammation and immunity has been studied in mouse strains with mutations in the gene encoding the stem-cell-factor receptor c-Kit, which are mast cell deficient, in mice lacking mast-cell-specific proteases and in mice with Crerecombinase-mediated deletion of mast cells or mast-cell-associated proteins 2, 29 . In some cases, newer genetic approaches have supported previous findings, confirming important roles for mast cells in IgE-dependent local and systemic anaphylaxis 29 , uric-acidcrystal-induced arthritis 30 , sensitization to food allergen 31 and resistance to animal venom 32 . In other models, such as contact hypersensitivity 33 , the Cre-mediated deletion of cells expressing mast cell protease 5 has contradicted early findings obtained with c-Kit-mutant strains by establishing a pro-inflammatory role for mast cells in sensitization to contact allergens. Such discrepant findings might reflect differences in protocols, the influence of Kit mutation beyond the mast-cell compartment or differential deletion of mast cell subsets in these strains. Additionally, some mast-cell-associated proteins, such as carboxypeptidase A3, used to direct Cre expression for the generation of the mast-cell-deficient Cre-Master and Hello Kitty strains, have been detected in basophils 34 , which are reduced in number in these strains. Thus, defining the genes and pathways uniquely or dominantly expressed in mast cells relative to their expression in other immune cells might clarify mast-cell functions, identify targets for Cre-mediated disruption and provide candidate loci for the generation of novel strains with mast-cell-specific expression of Cre.
Here we isolated constitutive connective-tissue mast cells from five distinct anatomical locations (the skin, the tongue, the esophagus, the trachea and the peritoneal cavity) and isolated basophils from two locations (the spleen and peripheral blood). Our data showed that the mast-cell transcriptome was distinct, with mast cells clustering independently from all other lymphoid and myeloid-cell populations analyzed. We found that basophils were transcriptionally closest to eosinophils and shared unexpectedly few distinct transcripts with mast cells. We demonstrated the unique transcriptional signatures of mast cells and basophils and found a small signature shared by the two cell populations. Among the mast-cell populations studied, we identified substantial heterogeneity in gene expression and found evidence for previously unappreciated connective-tissue mast-cell turnover in the periphery in the absence of tissue inflammation.
RESULTS

Mast cells are transcriptionally distinct among immunocytes
Mast cells were sorted on the basis of co-expression of FcεR1α and c-Kit (CD117) from the peritoneal cavity, the ear (where they reside in the dermis), the tongue (where they reside in the muscular layer), the trachea (where they reside in the submucosa and serosal tissue) and the esophagus (where they reside in the submucosa proximal to the stomach) ( Supplementary Fig. 1 ). Mast cells constituted between 0.05% and 10% of CD45 + cells in each compartment ( Fig. 1a) . Basophils were sorted on the basis of co-expression of FcεR1α and integrin CD49b from the spleen and peripheral blood, where they comprised 0.1% of CD45 + cells (Fig. 1a) . The gating strategy used for the isolation of mast cells (Supplementary Fig. 2a ) and basophils ( Supplementary Fig. 2b ) was validated through histochemical staining, which indicated that the cells isolated were morphologically mast cells and basophils ( Fig. 1b) . Cells underwent enrichment to high purity through multiple rounds of sorting ( Supplementary Fig. 3 ), and final purity was assessed with parallel samples ( Supplementary  Table 1 ). RNA extracted from sorted mast cells and basophils was assessed by microarray and compared with results in the ImmGen database obtained for immunocytes, including blood eosinophils; peritoneal macrophages and B-1a cells; and splenic dendritic cells, neutrophils, CD4 + T cells, CD8 + T cells, γδ T cells, B-2 cells, natural killer (NK) cells and NKT cells.
Hierarchical clustering using the top 15% of genes with the most variable expression showed that the five mast-cell populations sorted clustered separately from all other lymphoid and myeloid cells analyzed ( Fig. 1c) . Lymphoid cells and myeloid cells clustered independently, as expected, and the myeloid cluster was further divided into one group containing granulocytes (eosinophils, neutrophils and both basophil populations) and a second containing macrophages and dendritic cells (Fig. 1c) . The distinction of mast cells among immunocytes was based on both high expression of a distinct set of genes and low expression of many other transcripts associated with other cell types. Basophils had high expression of a smaller cluster of genes that had little overlap with the transcripts for which mast cells showed enrichment ( Fig. 1c) . Principal-component analysis further highlighted the distinction of mast cells from the other cell populations profiled, with mast cells from different tissues grouping closely with each other and distantly from other myeloid and lymphoid cells (Fig. 1d) .
The transcriptional relationships among mast cells, basophils and the other cell populations analyzed were quantified through Euclidean distance measurements ( Fig. 2a) , calculated using the top 15% of transcripts with the most variable expression ( Fig. 1c) . Among mast cells, the mast-cell subsets from the trachea, esophagus and tongue were the most similar, and the mast-cell subsets from the skin and peritoneum were the most different ( Fig. 2a) . Mast cells as a whole were closest to basophils and eosinophils and furthest from neutrophils ( Fig. 2a) . Basophils from the blood and spleen were very similar to each other and were closest to eosinophils ( Fig. 2a) . The distance between basophils and mast cells was similar to the distance between basophils and neutrophils ( Fig. 2a) . Pairwise comparison of dermal mast cells and blood basophils revealed differential expression of 2,563 transcripts at an arbitrary level of twofold or greater. Skin mast cells had higher expression of 1,428 transcripts, relative to their expression in blood basophils, whereas blood basophils had higher expression of 1,135 transcripts, relative to their expression in skin mast cells ( Fig. 2b) ; this further underscored their transcriptional differences. In contrast, pairwise comparison of blood eosinophils and blood basophils revealed differential expression of 1,372 transcripts at a level of twofold or higher. Blood eosinophils had higher expression of 503 transcripts, relative to their expression in blood basophils, whereas blood basophils had higher expression of 869 transcripts, relative to their expression in blood eosinophils ( Fig. 2c) . Thus, tissue-resident mast-cell populations expressed a gene program that distinguished them from other immunocytes.
Transcriptional signature of tissue-resident mast cells We next identified a transcriptional signature of 128 genes whose expression was twofold or greater in mast cells relative to their expression in all other cells analyzed ( Fig. 3a) . Functional analysis with the PANTHER pathway-classification system revealed that the mast-cell signature showed the most significant enrichment for genes encoding products in the category of 'serine proteases' , relative to the abundance of transcripts encoding products in other functional categories ( Table 1) . This group included transcripts for many canonical mast-cell proteases, as well as Plau, which encodes a urokinase-type plasminogen activator, Adamts9, which encodes a metalloprotease, and C2, which encodes complement component C2 of the classical C3 convertase ( Table 1 ). Mast cells also showed enrichment for the expression of Ctsg, which encodes cathepsin G; expression of this gene was more than fivefold higher in mast cells than in neutrophils ( Fig. 3b) . Additional pathways that showed enrichment in the mast-cell signature included 'sulfur metabolism' , which contained transcripts encoding enzymes important for heparin-sulfate biosynthesis, 'polysaccharide metabolism' and 'transferases' ( Table 1) . The last category included Hpgds, which encodes hematopoietic prostaglandin D 2 synthase, a factor important for synthesis of the mast-cell inflammatory product prostaglandin D 2 ( Table 1) . (a) Euclidean distance matrix indicating degree of similarity between selected cell populations calculated using the top 15% transcripts with the most variable expression (identified in Fig. 1c ); numbers in plot indicate Euclidean distance. (b) Gene expression in skin mast cells and blood basophils; dot colors indicate transcripts with expression values greater than 120 and expression twofold or higher in skin mast cells (aqua) or blood basophils (dark blue) than in the other population; numbers in plots indicate total genes expressed differentially in skin mast cells (top left) or blood basophils (bottom right). (c) Gene expression in blood eosinophils and blood basophils; dot colors indicate transcripts with expression values greater than 120 and expression twofold or higher in blood eosinophils (red) or blood basophils (dark blue) than in the other population; numbers in plots indicate total genes expressed differentially in blood eosinophils (top left) or blood basophils (bottom right). Data are pooled from three (skin, tongue and tracheal mast cells; splenic and blood basophils; blood eosinophils), five (peritoneal mast cells) or two (all other populations) independent experiments.
Five of the genes encoding products in the 'signal-transduction' pathway encoded members of the Mrgpr family of G-protein-coupled receptors: Mrgpra4, Mrpgrb1, Mrgprb2, Mrgprx1 and Mrgprx2. One of these, Mrgprb2, has been described as the homolog to the human gene MRGPRX2. The protein encoded mediates mast-cell activation in response to a broad array of stimuli ranging from wasp venom to several pharmaceutical compounds associated with IgE-independent pseudoallergic reactions in patients 35 . In addition to the five Mrgprencoding transcripts in the mast cell signature, Mrgprb8 and Mrgprb13 had high expression specifically in skin mast cells, while Mrgpra6
Eosinophil Neutrophil npg r e s o u r c e had high expression in basophils ( Fig. 3c ).
Mrgpra2a and Mrgpra2b were expressed predominantly by neutrophils, as previously reported 36 , but were also detected in all mastcell populations, and Mrgpre was detected in B cells and NKT cells, in addition to being detected in mast cells ( Fig. 3c) . Thus, the unique mast-cell transcriptional program included a broader degree of proteases, biosynthetic enzymes and receptors of the Mrgpr family than previously appreciated.
Distinct and shared gene expression
A basophil transcriptional signature of 66 transcripts was similarly calculated on the basis of twofold-or-greater expression in both basophil populations relative to the expression in all other cell populations analyzed, including mast cells (Fig. 4a) .
The basophil signature contained a single protease-encoding transcript, Mcpt8. The basophil signature also included transcripts from several genes encoding chemokines (Ccl3, Ccl4 and Ccl9), growth factors (Hgf and Bmp4) and adhesion proteins (Cdh1 and Itga1). This suggested mechanisms through which the basophil might interact with and influence the local environment.
To better understand the relationship between mast cells and basophils, we derived a shared signature on the basis of twofold-higher expression of transcripts in all basophil and mast-cell subsets than in any other population analyzed. This analysis revealed a small shared transcriptional signature consisting of only 24 genes ( Fig. 4b) , many of which have previously been characterized in mast cells and basophils. These included Cd200r3, which encodes an activating receptor; Fcer1a and Ms4a2, which encode the αand β chains, respectively, of the high-affinity receptor for IgE; Slc24a3, which encodes a Ca 2+ transporter; and Gata2, which encodes a transcription factor that directs the differentiation and function of both cell types 37 . The protease-encoding transcript Cpa3 was also present in the shared signature, consistent with published reports of high expression of this transcript by basophils 38 , in addition to mast cells.
Mast cells and basophils are well-known sources of histamine 2 . Consistent with that, the mast cell-basophil shared profile identified here included the transcript encoding Slc18a2, a solute transporter involved in loading histamine into secretory vesicles (Fig. 4b) . Further analysis of the monoamine-biosynthetic pathways indicated that both mast cells and basophils had high expression of transcripts encoding r e s o u r c e a histidine transporter (Slc3a2) and histidine decarboxylase (Hdc) ( Fig. 4c) . Mast cells further expressed transcripts encoding an l-tryptophan transporter (Slc7a5), tryptophan hydrolase (Tph1) and DOPA decarboxylase (Ddc) (Fig. 4c) . The mast-cell signature also included Maob, which encodes a monoamine oxidase ( Fig. 4c) , consistent with published reports 39 . Mast cells and basophils both expressed transcripts encoding a histamine receptor (Hrh4) and serotonin re-uptake transporter (Slc6a4) ( Fig. 4c) , while basophils expressed transcript encoding a serotonin receptor (Htr1b) (Fig. 4c) .
Several transcription factors had higher expression in either mast cells or basophils than in other immunocytes. The mast-cell signature included Creb3l1, Mitf, Smarca1 and Zfp9 (Fig. 4d ). Of these, to our knowledge, only Mitf has been previously reported in mast-cell biology, as the transcription factor encoded regulates expression of the genes encoding c-Kit and mast cell proteases 40 . The basophil signature included Sncaip, Cebpa, Supt3h and Nfil3 (Fig. 4d ). Of these, only C/EBP-α (encoded by Cebpa) has been previously reported to have an important role in basophil biology 28 , in which it directs the commitment of progenitor cells to the basophil lineage. GATA-2 (encoded by Gata2) was the only transcription factor in the signature shared by mast cells and basophils (Fig. 4d) . The diverse transcription factors, cell-surface receptors and inflammatory-cell proteins expressed by mast cells and basophils extended our earlier cluster analysis ( Fig. 1c) and pairwise analysis ( Fig. 2b) and indicated that these cell types are not closely related in function.
Comparison of mast-cell and basophil signatures across species
Next we used a FANTOM consortium data set that defined the resting transcriptome of human dermal mast cells and blood basophils 41 to evaluate the mast-cell and basophil signatures across species. Human skin mast cells showed significant enrichment for expression of the mouse mast-cell signature, with 55 of the 82 mast-cellsignature genes in both data sets having twofold higher expression in human skin mast cells than in human blood basophils (Fig. 5) . The transcripts conserved across species included those encoding proteases, hematopoietic prostaglandin D 2 synthase, members of the Mrgpr family, and c-Kit (Supplementary Table 2) . Other transcripts conserved across species encoded products with less-well-defined roles; these included Maob and Gnai1 (which encodes a G protein) (Fig. 5) .
In contrast, human basophils did not show significant enrichment for the mouse basophil signature, with only 10 of the 44 signature genes present in both data sets having expression twofold higher in humanblood basophils than in human skin mast cells (Supplementary Table 3) . Among the transcripts conserved in human and mouse basophils were those encoding the chemokines CCL3 and CCL4 (Fig. 5) , suggestive of a shared role for basophils across species in recruiting other leukocytes to sites of inflammation. Human mast cells showed enrichment (relative to its expression in human basophils) for the signature shared by mouse mast cells and basophils, with transcripts such as Cpa3 having expression 7.6-fold higher and Gata2 having expression 5.2-fold higher in human mast cells than in human basophils ( Supplementary Table 4 ), which again demonstrated the conserved nature of the mast-cell transcriptional program across species.
Tissue-specific genetic programs among mast-cell populations Next we assessed the diversity among mast-cell subsets through pairwise comparison. Because peritoneal mast cells were the only mast-cell population derived from undigested tissue, we first assessed the effect of digestion enzymes on mast-cell transcription. Enzymatic treatment of peritoneal mast cells increased the expression of 137 genes by twofold or more relative to their expression in untreated cells, including 17 genes whose expression increased five-to tenfold and 7 genes (such as Ccl3, Il13 and the transcription-factor-encoding gene Egr2) whose expression increased more than tenfold (Supplementary Fig. 4a ). Enzymatic digestion decreased the expression of 26 genes by twofold or more relative to their expression in untreated cells, including one transcript (Myl1, which encodes the myosin light-chain protein) whose expression decreased five-to tenfold (Supplementary Fig. 4b) .
None of these genes were mast-cell signature genes, and hierarchical clustering of mast cells with enzymatically treated peritoneal mast cells again demonstrated that peritoneal mast cells were the most transcriptionally distinct subset (Supplementary Fig. 5 ). However, because a subset of genes underwent transcriptional alteration by such treatment, we used enzymatically treated peritoneal mast cells for subsequent comparison with other mast cell populations.
Mast cells from the tongue showed high homology with mast cells from either the trachea or the esophagus, with only 110 genes showing a difference in expression of twofold or greater in mast cells from the tongue relative to their expression in mast cells from the trachea (Fig. 6a) , and only 122 genes showing a difference in expression in mast cells from the tongue relative to their expression in mast cells from the esophagus (Fig. 6b) . In contrast, mast cells from the tongue and peritoneum had differential expression of 612 transcripts (Fig. 6c) , and mast cells from the peritoneum and skin had differential expression of 957 genes (Fig. 6c) , which indicated these two mast-cell subsets were the most distinct in this comparison.
We next analyzed transcripts with a difference in expression of fourfold or more in single mast-cell subset relative to their expression in all npg r e s o u r c e other mast-cell populations. Consistent with the transcriptional similarity of mast cells from the trachea, esophagus and tongue, mast cells from the tongue had no transcripts with a difference in expression of fourfold or more relative to their expression in the other mastcell subsets (data not shown). The expression of five transcripts was at least fourfold higher in mast cells from the esophagus than in other mast cells; these included the proteaseencoding transcripts Mcpt1 (whose expression was limited to this subset) and Mcpt2 (Fig. 6d) . Tracheal mast cells had fourfold higher expression of a single transcript, Lipf (Fig. 6e) . No transcript had expression fourfold lower in mast cells from the trachea or esophagus relative to its expression in other mast cell populations (data not shown). The expression of three transcripts, including Itgb2 (which encodes integrin β 2 (ItgB2)) and Bmp2 (which encodes a bone-morphogenic protein), was fourfold higher in peritoneal mast cells than in other mast cells (Fig. 6f) . The expression of ten transcripts, including Cd59a (which encodes a membrane-attack-complex inhibitor) and Olr1 (which encodes an oxidized lipoprotein receptor), was more than fourfold lower in peritoneal mast cells than in other mast cells (Fig. 6f) . Skin mast cells showed fourfold higher expression of 28 genes and fourfold lower expression of 18 genes relative to their expression in the other mast cell subsets (Fig. 6g) . In addition to having higher expression of Mrgprb8 and Mrgprb13, skin mast cells showed increased expression of transcripts encoding the metalloproteases ADAMTS1 and ADAMTS5, the cytokine and mast-cell growth factor IL-3 and the transcription factor SOX7. Skin mast cells also showed enhanced expression of CD59a, which suggested substantially different expression of this gene in mast cells from the skin and those from the peritoneum. Transcripts with expression fourfold lower or more in skin mast cells relative to their expression in other subsets of mast cells included Cd34 (which encodes a canonical mast-cell marker) and Alox5 and Alox5ap (which encode 5-lipoxygenase and 5-lipoxygenase-activating protein, respectively).
In support of the transcriptional data, analysis by flow cytometry indicated that the adhesion molecule CD34 was expressed on all mastcell subsets except for skin mast cells, CD59a expression was highest on skin mast cells and was undetectable on peritoneal mast cells, and ItgB2 expression was detected only on peritoneal mast cells (Fig. 6h) . Enzymatically treated peritoneal mast cells showed no decrease in surface staining of either CD34 or ItgB2 relative to surface staining of these proteins on their untreated counterparts (Supplementary Fig. 6 ).
Because the skin and peritoneal mast-cell populations showed the greatest degree of differential gene expression, we compared these populations by gene-set-enrichment analysis (GSEA). Among the terms of the Gene Ontology (GO) Consortium most 'enriched' in Cpa3 r e s o u r c e peritoneal mast cells were 'Mitosis' and 'M phase' (Fig. 7a) , which suggested that peritoneal mast cells might be undergoing cellular turnover. Thus, we evaluated peritoneal-mast-cell expression of Ki67, a nuclear protein present during mitosis but rapidly degraded during the G-0 phase. Ki67 staining was greater in peritoneal mast cells than in skin mast cells, which also expressed Ki67 (Fig. 7b) . In total, 16% of peritoneal mast cells were positive for Ki67, compared with only 4% of skin mast cells (Fig. 7c) , which indicated a much higher rate of mitosis in the peritoneal-mast-cell population and notable Ki67 expression in both populations in the absence of inflammation.
DISCUSSION
Heparin-containing mast-cell-like cells are found as far back as urochordates 3 , and although mast cells were first identified over 100 years ago, their contribution to immunological defense and disease has been poorly defined. Here we have provided a comprehensive transcriptional analysis of mouse mast cells in comparison with 14 other lymphoid and myeloid cell populations. We identified mast cells as the most transcriptionally distinct cell type, as they clustered independently Figure 5 Enrichment for expression of the mouse mast-cell signature in human mast cells. Expression of all 10,773 transcripts represented in both the ImmGen consortium data set (mouse) and the FANTOM consortium data sets (human), in human skin mast cells versus human blood basophils (horizontal axis) or in mouse skin mast cells versus mouse blood basophils (vertical axis); blue lines indicate cutoff for a twofold difference in expression. Human mast cells show significant enrichment for expression of the mouse mast-cell signature (82 transcripts, red) (P = 5.5 × 10 −16 ) and the signature shared by mast cells and basophils (17 transcripts; green) (P = 0.0028, hypergeometric cumulative distribution upper tail); human blood basophils do not show enrichment for expression of the mouse basophil signature (44 transcripts; blue) (P = 0.33). Data are from three independent experiments (mouse mast cells and mouse basophils) or three independent donors (human mast cells and human basophils) 41 . 10 2 10 3 10 4 10 5 0 10 2 10 3 10 4 10 5 0 10 2 10 3 10 4 10 5 0 10 2 10 3 10 4 10 5 0 10 2 10 3 10 4 10 5 0 10 2 10 3 10 4 10 5 0 10 2 10 3 10 4 10 5 0 10 2 10 3 10 4 10 5 0 10 2 10 3 10 4 10 5 0 10 2 10 3 10 4 10 5 0 10 2 10 3 10 4 10 5 0 10 2 10 3 10 4 10 5 0 10 2 10 3 10 4 10 5 0 10 2 10 3 10 4 10 5 0 Figure 6 Tissue-specific mast-cell gene expression. (a-c) Comparison of gene expression in various mast-cell subsets (axes); dot colors indicate transcripts with expression values greater than 120 and twofold or higher expression in tongue mast cells (light green), tracheal mast cells (red), esophageal mast cells (pink), peritoneal mast cells (dark blue) or skin mast cells (aqua) than in the other population plotted; numbers in plots indicate total differentially expressed genes along the vertical axis (top left) or horizontal axis (bottom right). (d-g) Transcripts with expression at least fourfold higher or lower in mast cells from the esophagus (d), trachea (e), peritoneum (f) or skin (g) than in any other mast cell population. (h) Flow cytometry of mast cells from various tissues (left margin) assessing the expression (black lines) of CD34, CD59a and ItgB2 (to confirm differential gene expression suggested by transcript data). Gray shaded curves, isotype-matched control antibody. Data are pooled from three (skin, tongue and tracheal mast cells), five (peritoneal mast cells) or two (esophageal mast cells) independent experiments (a-g) or are representative of three independent experiments (h).
npg r e s o u r c e from all other populations, including basophils. We described a shared mast-cell transcriptional signature and further recognized tissue-specific regulation of the mast-cell transcriptome. We found that mast cells expressed genes encoding proteins involved in sensing and responding to environmental cues; this should provide a framework for understanding their sentinel function.
Mast cells from various tissues shared a transcriptional signature of 128 genes, among which those encoding serine proteases were a substantial contributor. Mast cells also showed enrichment for the expression of genes encoding products in metabolic pathways required for the generation of a broad range of other preformed mediators, including histamine, serotonin and heparin sulfate. Furthermore, mast cells expressed transcripts encoding products that allow the acute generation of eicosanoids such as prostaglandin D 2 and the rapid production of cytokines and chemokines. Together these findings indicate an ability to generate a unique repertoire of mediators. Human mast cells also showed substantial enrichment for expression of the mouse mast-cell signature, suggestive of evolutionary pressures to retain a core mast-cell functionality. These highly conserved genes included well-known mast-cell genes, such as those encoding proteases, and Hpgds, as well as several that are poorly understood in the context of mast cells, including Maob, Gnai1 and genes encoding members of the Mrgpr family.
The array of Mrgpr-family members expressed in mast cells was broader than previously appreciated. Originally discovered in sensory neurons 42 , eight members of this family were expressed in skin mast cells and six were expressed in the other mast-cell populations. Further analysis showing expression of Mrgpra6 in basophils and of Mrgpra2a and Mrgpra2b in neutrophils suggested that the Mrgpr family might have an important role in the innate immune system. MRGPRX2 has been shown to mediate mast cell degranulation in response to the classical mast-cell-activating compound 48/80 in human-cordblood-derived mast cells 43 and the transformed human LAD2 mastcell line 44 . The mouse homolog of MRGPRX2, Mrgprb2, mediates degranulation in response to wasp venom, 48/80 and a diverse array of other basic compounds, including therapeutic agents that induce IgE-independent pseudoallergic reactions in humans 35 . Thus, members of this family might have a critical role in mediating the innate activation of mast cells in response to both pharmacological agents and as-yet-unidentified native ligands.
The low homology between mouse mast cells and mouse basophils observed in this study is similar to that previously observed for human cells, as is the closer relationship between basophils and eosinophils 41 . While mouse mast cells and basophils shared expression of transcripts encoding several activating receptors and histamine-biosynthetic enzymes, basophils lacked the diversity of proteases seen in mast cells and expressed different combinations of soluble mediators and receptors. Thus, our transcriptional analysis of mast cells and basophils suggested that these cells have independent roles in regulating homeostasis and host defense, rather than serving similar roles in different tissue compartments. The basophil signature included Ccl3, Ccl4 and Ccl9. Human basophils showed enrichment for the expression of two of these transcripts, Ccl4 and Ccl4, relative to their expression in human mast cells, which suggested a conserved role for the encoded chemokines in directing cellular recruitment. However, the poor conservation between human basophils and mouse basophils in their expression of other genes in the basophil signature might reflect evolutionary pressures drove divergence of this cell type in these species.
Comparative analysis of mast-cell populations revealed considerable tissue-specific gene expression, consistent with mast-cell maturation in peripheral tissue and with studies demonstrating regulation of mast cells by neighboring fibroblasts 21, 45 . Unlike other mast-cell populations, peritoneal mast cells are not embedded in the tissue but instead line the serosal gut wall. We observed that they showed 'enrichment' for transcriptional pathways associated with cellular turnover, which led to the finding that a substantial fraction of peritoneal mast cells stained positively for Ki67. Thus, the profound transcriptional differences between peritoneal mast cells and other mast-cell compartments might reflect both cell maturation and differential signaling from neighboring cells. Notably, Ki67 staining was also detectable at low levels in skin mast cells, which suggested that local proliferation might have a role in the renewal and maintenance of this compartment.
In conclusion, we found that mast cells were extraordinarily distinct at the transcriptional level. Their core signature showed enrichment for the expression of genes encoding a diverse array of proteases and factors involved in biosynthetic pathways, which would allow the generation of a broad range of mediators, and included several novel gene families whose product function is not yet understood. Analysis of mast-cell heterogeneity revealed three distinct connective-tissue mast-cell subsets and varying capacity for in situ proliferation in the absence of tissue inflammation. These findings provide a framework for better definition of the role of these evolutionarily ancient cells in homeostasis, host defense and disease.
METhODS
Methods and any associated references are available in the online version of the paper. 
ONLINE METhODS
Mice. All cells used for transcriptional and flow cytometric analyses were obtained from male 6-week-old C57BL/6J mice and tissue used for histology was obtained from male 6-to 10-week-old C57BL/6J mice from the Jackson Laboratory. Mice were housed (four mice per cage) in specific pathogen-free facilities at the Dana Farber Cancer Institute (DFCI) under a 12 h light/ 12 h dark cycle. The use of all mice for these studies was in accordance with institutional guidelines with review and approval by the Animal Care and Use Committee of DFCI.
Cell isolation and sorting. Cells were purified according to the standardized ImmGen standard operations protocol (http://www.immgen.org/Protocols/I mmGen%20Cell%20prep%20and%20sorting%20SOP.pdf) using the indicated antibodies (identified below) with modifications for increased digestion time as noted below. Peritoneal cell suspensions were obtained by lavage of the peritoneal cavity with 7 ml HBSS containing 1 mM EDcell TA. Single-cell suspensions were obtained from tongue, esophagus, and trachea by finely mincing tissue between two scalpel blades and incubating for 30 min at 37 °C with 600 U/ml collagenase IV (Worthington), 0.1% dispase (Gibco) and 20 µg/ml DNAse 1 (Roche) in RPMI supplemented with 10% FBS at 500 RPM. Ear digests were obtained using modifications of a previously described protocol 46 . Briefly, dorsal and ventral halves of the ear were separated and incubated for 20 min in HBSS with 2.5 µg/ml dispase at 300 RPM to separate the epidermis. After pulling away the epidermis, remaining tissue was finely minced between two scalpel blades and incubated for 30 min with 600 U/ml collagenase IV and 20 µg/ml DNAse 1 in RPMI supplemented with 10% FBS at 500 RPM. Spleen suspensions were obtained through mechanical disruption of the spleen followed by erythrocyte lysis using ACK buffer (Sigma). Following lysis, lymphocytes were depleted using Dynal beads directed against B220 and Thy1.2 (Invitrogen). Blood was obtained through cardiac puncture and erythrocytes were depleted using a 44%/67% Percol gradient (Sigma). Mast cells were identified as CD45 + CD11b − CD11c − CD19 − CD4 − CD8 − FcεR1α + C D117 + . Basophils were identified as CD3 − CD19 − NK1.1 − CD117 − FcεR1α + C D49b + . Cells were sorted at the Brigham and Women's Human Immunology Flow Core using a BD FACSAria Fusion cell sorter. For surface marker and intracellular analysis, data was acquired on a BD FACSCanto II and analyzed with FlowJo software (Treestar). The following monoclonal antibodies (clone, concentration) were used: anti-FcεR1α (MAR-1, 1:250), anti-CD117 (2B8, 1:250), anti-CD45 (30-F11, 1:250), anti-CD11b (M1/70, 1:250), anti-CD11c (N418, 1:250), anti-CD19 (6D5, 1:250), anti-CD4 (GK1.5, 1:250), anti-CD8 (53-6.7, 1:250), anti-CD49b (DX5, 1:250), anti-NK1.1 (PK136, 1:250), anti-CD34 (MEC14.7, 1:250), anti-CD59b (mCD59.3, 1:250), anti-ItgB2 (M18/2, 1:250), and isotype-matched control monoclonal antibodies (mAbs) were obtained from BioLegend. Anti-IgE (23G3 1:250), anti-Ki67 (SolA15, 1:100), isotype-matched control mAbs, and FoxP3 staining buffer set used for Ki67 staining were obtained from eBioscience.
Cytospins and microscopy.
For histochemical evaluation of mature mast cells in peripheral tissues, tissue sections were fixed overnight in 4% paraformaldehyde and embedded in glycolmethacrylate. For cytospin evaluation, sorted cells were spun onto charged glass slides and dried overnight. Cut section and cytospins were stained for chloracetate esterase reactivity for the identification of mast cells, and cytospins were stained with toluidine blue for the identification of basophils.
Cells and animals per microarray replicate. Mast cells were collected from the skin (n = 3, each replicate was 25,000 cells pooled from 8 mice), peritoneal cavity (n = 5, each replicate was 30,000 cells pooled from 4 mice), tongue (n = 3, each replicate was 10,000 cells pooled from 10 mice), esophagus (n = 2, each replicate was 10,000 cells pooled from 24 mice), and trachea (n = 3, each replicate was 15,000 cells pooled from 8 mice). Basophils were collected from the blood (n = 3, each replicate was 10,000 cells pooled from 5 mice) and spleen (n = 3, each replicates was 25,000 cells pooled from 4 mice). Whenever possible, multiple tissues were harvested from each mouse to minimize total number of animals used. Sample sizes were determined based on ImmGen standard protocols targeting a minimum of 10,000 cells per microarray sample.
Microarray analysis and data evaluation. Samples were sorted twice and collected directly into TRIzol. RNA was amplified and hybridized to the Affymetrix Mouse Gene 1.0 ST array by ImmGen according to the consortium's standard protocols (https://www.immgen.org/Protocols/Total%20RNA%20Extraction% 20with%20Trizol.pdf) with modification. To improve microarray success rate, RNA was treated with heparinase as previously described 47, 48 . Briefly, following an initial round of chloroform extraction, RNA was incubated in 5 µm Tris buffer containing 50U of RNAsin plus (Promega) and 0.02 U of heparinase (Sigma) for 2 h at room temperature, and then subjected to a second round of TRIzol extraction. Comparison of peritoneal mast cell RNA treated with heparinase (n = 3) or control showed that 4 transcripts among the 21,775 assayed were reduced by a twofold statistically significant (P < 0.05) degree, demonstrating minimal impact on detected transcript levels. Data generation and quality-control documentation was also conducted by ImmGen according to the consortium's standard protocols (https://www.immgen.org/Protocols/ ImmGen%20QC%20Documentation_ALL-DataGeneration_0612.pdf ). Transcripts identified through multiple probes were collapsed based on median values and differential gene expression was characterized using the Multiplot Studio module of GenePattern software (Broad Institute). Tracheal mast cells were found to be enriched for several B cell genes, including immunoglobulin genes, suggesting B cell contamination. Contaminating B cell genes in tracheal mast cells were identified by comparing fold changes in expression between tracheal mast cells and esophagus mast cells to fold changes in expression between esophagus mast cells and splenic B cells. All transcripts with greater than 16-fold increased expression in splenic B cells compared to tongue mast cells also showed increased expression in tracheal mast cells compared to tongue mast cells and were excluded from all pairwise comparisons. Hierarchical clustering for transcripts was conducted using Gene-E (http://broadinstitute.org/cancer/software/GENE-E) based on the top 15% most variable transcripts using Pearson's correlation and cell population clustering was calculated using Spearman's correlation. Euclidean distance matrix and all transcript heat maps were also constructed using Gene-E. Principal component analysis was visualized using MatLab software (MathWorks) using principal components calculated using the PopulationDistances PCA program (S. Davis, Harvard Medical School) based on the top 15% most variable transcripts across all analyzed cell populations. The skin and enzyme-treated peritoneal-mast-cell transcriptomes were further compared using the Gene Set Enrichment Analysis software program (Broad Institute) 49, 50 using Gene Ontology Consortium (www.geneontology.org) gene sets.
Controlling for the effects of collagenase treatment on peritoneal mast cells.
Peritoneal cell suspensions obtained by lavaging the peritoneal cavity with 7 ml HBSS containing 1 mM EDTA were incubated for 30 min at 37 °C with 600 U/ml collagenase IV (Worthington), 0.1% dispase (Gibco) and 20 µg/ml DNAse 1 (Roche) in RPMI supplemented with 10% FBS. Following enzymatic treatment, peritoneal mast cells were either isolated for microarray analysis or stained for cell surface marker expression.
Derivation of mast-cell and basophil transcriptional signatures.
The mastcell signature was generated in comparison to all cell populations analyzed.
Multiple replicates for each cell population were collapsed based on median values. Transcripts in the mast-cell signature were expressed at least twofold higher in all mast-cell populations than in any non-mast-cell population, including basophils. All transcripts expressed below 120 relative units in more than two mast-cell subsets were excluded, as were all in which there was no statistically significant difference between mast-cell and non-mast-cell expression by student's t-test. The mast-cell signature was calculated using non-digested peritoneal mast cells to exclude any genes induced by collagenase and dispase treatment. The basophil signature was calculated similarly, and the shared mast-cell and basophil signature was calculated by determining all transcripts expressed at least two fold higher in both mast cell and basophil than in any non-mast cell and non-basophil. After calculating the signatures, enriched pathways were determined using DAVID software 51,52 based on the PANTHER classification system with P < 0.05. Mast-cell-and basophilspecific transcription factors were determined by identifying transcripts in the individual and shared mast-cell and basophil signatures that also npg appeared in the Riken institute transcription factor database (http://genome. gsc.riken.jp/TFdb/).
Comparison of human and mouse mast cells and basophils.
All 10,773 transcripts identified in both the Affymetrix Mouse 1.0 array and in human cells via CAGE sequencing were visualized on a fold change vs fold change plot.
To allow for fold change comparisons in the CAGE sequencing data set, in which numerous transcript levels had a value of zero, a value of 1 was added to each datapoint. Genes found in the mouse mast cell, basophil and combined signatures were then highlighted.
Statistics.
There was no randomization, blinding, or exclusion of data. Sample size was not predetermined statistically. Significance of PANTHER pathway enrichment was determined using a modified Fisher's exact test in DAVID. Enrichment of human mast cells and basophils for the mouse mast-cell and basophil signatures was evaluated using the hypergeometric cumulative distribution upper tail in Matlab (Mathworks). Differences in intracellular Ki67 levels were evaluated using Prism 6.0 (GraphPad) with a two-tailed unpaired t-test with Welch's correction after determining that the samples represented a gausian distribution using the D' Agostino & Pearson omnibus normality test. P values of < 0.05 were considered statistically significant.
